| 6,970.00 Data as of 3:00pm ET | Today’s Change | 5,030.00 Today|||52-Week Range 7,420.00 | +15.40% Year-to-Date |
| Previous close | 6,970.00 |
| Today’s open | 6,930.00 |
| Day’s range | 6,800.00 - 6,990.00 |
| Volume | 60,820 |
| Average volume (3 months) | 129,970 |
| Market cap | -- |
| Dividend yield | 1.15% |
| Earnings growth (last year) | -92.58% |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -4.77% |
| P/E ratio | -- |
| Price/Sales | -- |
| Price/Book | 0.00 |
| Today’s change | Today’s % change | |
|---|---|---|
| --iNtRON Biotechnology... | +150.00 | +0.80% |
| --Whanin Pharm Co Ltd | 0.00 | 0.00% |
| --Samjin Pharmaceutica... | 0.00 | 0.00% |
| --Theragen Etex Co Ltd | +270.00 | +3.70% |
| Last reporting date | July 5, 2007 |
| EPS forecast (this quarter) | $28.32 |
| Annual revenue (last year) | -- |
| Annual profit (last year) | -- |
| Net profit margin | 0.59% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman & Co-Chief Executive Officer Do-Joon Yoon, MD |
President, Co-Chief Executive Officer & Director Chang-Soo Cho |
Corporate headquarters Seoul, -- |
